- Preliminary communication
- Open Access
Reaction of pharmacological active tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate with ZnCl2 or NiCl2: first conversion of a protic ionic liquid into metallated ionic liquid
© Mirskova et al; licensee Chemistry Central Ltd. 2013
- Received: 5 December 2012
- Accepted: 11 February 2013
- Published: 19 February 2013
The reaction of pharmacological active protic ionic liquid tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate H+N(CH2CH2OH)3 ∙ (-OOCCH2SC6H4Cl-4) (1) with zinc or nickel chloride in a ratio of 2:1 affords stable at room temperature powder-like adducts [H+N(CH2CH2OH)3]2 ∙ [M(OOCCH2SC6H4Cl-4)2Cl2]2-, M = Zn (2), Ni (3). By recrystallization from aqueous alcohol compound 2 unexpectedly gives Zn(OOCCH2SC6H4Cl-4)2 ∙ 2H2O (4). Unlike 2, compound 3 gives crystals [N(CH2CH2OH)3]2Ni2+ · [-OOCCH2SC6H4Cl-4]2 (5), which have a structure of metallated ionic liquid. The structure of 5 has been proved by X-ray diffraction analysis. It is the first example of the conversion of a protic ionic liquid into potentially biological active metallated ionic liquid (1 → 3 → 5).
- Ionic Liquid
- Acetate Dihydrate
- Aqueous Alcohol
- Colorless Powder
Alkanolammonium salts of inorganic and carbonic acids, also known as protic ionic liquids (PILs), have been the subject of many studies [1, 2]. Depending on cation and anion structure, PILs can be liquid (room temperature ionic liquids)  or solid compounds with m.p. up to 100°С and even higher (176°С ). For example, 2-hydroxyethylammonium nitrate, H3+NCH2CH2OH ∙ NO3-, synthesized in 1888, has m.p. 52°С . At the same time, 2-hydroxy-ethylammonium formiate, H3+NCH2CH2OH ∙ -OOCН, represents a typical room temperature PIL with extremely low freezing point (−82°С) . Alkanolammonium PILs are used as catalysts in chemical reactions, as electrolytes in full cells, gas (such as CO2 and SO2) solvents and crystaline cellulose solvents, for desulfurization of fuel, enzymes stabilizers and promoters of their activity and for protein purification [6–10]. Also, they are employed for the design of nano-structured compounds . Their toxicity and biological degradation have been studied [12, 13].
Among the objects of our previous investigations were PILs containing cations of biologically active 2-hydroxyethylamines and anions of aroxy- and aryl(heteryl)sulfanyl(sulfonyl)acetic acids R1R2N+H(CH2CH2OH)3-n ∙ (-OOCCH2XR), R = Ar, Het; R1, R2 = H, Alk; X = O, S, SO2; n = 0–2.
These PILs are air-stable solids (m.p. 37-95оС) or viscous liquids, well soluble in water and polar solvents, representing a new class of pharmacologically active substances. Showing low toxicity (LD50 = 1500–6000 mg/kg), they possess antiaggregation, antithrombotic, membrane-stabilizing, antioxidant, antisclerotic, adaptogenic, analgesic, cardiotropic, hypocholesterolemic, hemo- and immunotropic activities. These PILs protect the mammalians and humans from shock, toxic stress, alcohol and heavy metal intoxication, and radiation. Their antitumor activity considerably exceeds or differs from the effect of the initial biologically active acids and alkanolamine [14–19].
They also exert pronounced growth-stimulating activity at very low concentrations (10–4 - 10–10 wt %) toward beneficial bacteria, yeasts, and fungi used in large-scale biotechnology processes (white biotechnology ) for manufacture of fodder, baker’s yeasts and citric acid, barley sprouting for the preparation of brewer’s malt, and breeding of silkworms .
Recently we have shown that metallated ionic liquid tris-(2-hydroxyethyl)amine-bis-(2-methylphenoxyacetate)zinc N(CН2СН2ОН)3Zn2+ · 2(-ООССН2OC6H4-Me-2) exhibits a pronounced anti-sclerotic effect .
We have assumed that the incorporation of essential metals (so-called “metals of life”), which are of vital importance for all living organisms: Ca, Mg, Zn, Mn, Cu, Fe, Co, Ni, etc. [23, 24], can enhance or alter the biological activity of protic alkanolammonium ionic liquids.
To reach this goal, in this work we have studied the reaction of PIL tris-(2-hydroxyethyl)-ammonium 4-chlorophenylsulfanylacetate (1) (a non-toxic compound possessing antithrombotic, antioxidant and immunotropic activity) with Zn and Ni chlorides.
According to the data of IR spectroscopy, the compounds 2 and 3 contain coordination bonds HО···M with the ОН groups of two molecules of protonated triethanolamine and coordination bonds M-О with two carboxylate anions of 4-chlorophenylsulfanylacetic acid. So, the IR spectrum of 3 shows the absorption bands ν(Ni-ОС) 396 cm-1, νas(COO−) and νs(COO−) at 1583 and 1401 cm-1, Δν = νas(COO−) - νs(COO−) = 182 cm-1, characterizing bidentate coordination bonds of nickel atom with carboxylate anions; absorption bands typical for protonated triethanolamine HN+(CH2CH2OH)3 at 548, 549 and 397 cm-1, ν(N+H) is a broad band at 2500–2700 cm-1; absorption band of the OH group at 3312 cm-1.
The Ni(II) cation is coordinated by four oxygen atoms of the hydroxyl groups and two nitrogen atoms forming an weakly distorted octahedral coordination environment. The asymmetric unit contains only the half of the cationic moiety. Because nickel is located on an inversion centre the second half is generated by inversion. The nitrogen atoms occupy the trans positions of the coordination polyhedron. Resulting from symmetry, the Ni-N bond lengths are equal being 2.097(2) Å, and the N-Ni-N bond angle is 180°. The Ni-O distances are 2.062(2) Å and 2.070(2) Å. One hydroxyl group of each ethanol substituent is not involved in the coordination and directed away from the coordination centre. The N-Ni-O bond angles range from 81.50(7)° to 98.50(7)° and the O-Ni-O bond angles between 85.12(7)° and 94.88(7)°. Previously, structures containing the bis(triethanolamine)nickel (II) cation were described [25, 26]. The 4-chloro-phenylsulfanyl unit is planar. The acetate substituent and the phenyl ring are almost in a tetrahedral arrangement with a C-S-C angle of 101.4(1)°. The carboxylic group is rotated around the S-C bond characterized by a C-S-C-C torson angle of −50.7(3)°. Cations and anions are linked by hydrogen bonds (see Figure 2). All oxygen atoms of the OH groups of tris-(2-hydroxy-ethyl)amine are involved in hydrogen bonds. Strong hydrogen bonds can be observed between those oxygen atoms, which are coordinated to the metal centre and both oxygen atoms of one carboxylic moiety. More weak hydrogen bonds are formed between the non-coordinated peripheric oxygen atoms of the OH groups and one oxygen atom of a carboxylic group. One oxygen atom (O4) of the carboxylic group forms bifurcurated hydrogen bonds, one to the coordinated oxygen atom O3 and another one to the noncoordinated oxygen atom O3. That leads to a three-dimensional polymeric network.
IR spectra (ν, cm–1) were recorded on a Varian 3100 FT- IR75 spectrophotometer (KBr). NMR spectra (δ, ppm) were measured on a DPX 400 instrument at 25°С. Reflections were collected using a STOE Imaging Plate Diffraction System (IPDS-II) at 210 K. The data were corrected for Lorentz, polarisation and extinction effects. No absorption correction was applied. The structure was solved by direct methods as implemented in the program SHELXS-97 . The refinement was carried out using SHELXL-97 . All the non-hydrogen atoms were refined anisotropically. The hydrogen atoms of the phenyl groups were calculated in their expected positions. All the other hydrogen bonds were located from the difference Fourier map. The hydrogen atoms were refined isotropically. For the phenyl and methylene hydrogen atoms a riding model was used. The other hydrogen atoms were free refined. For the visualisation of the structure the program DIAMOND  was applied. CIF data: Additional file 1. CCDC reference number: 876072.
Tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate ( 1)  was synthesized in the following manner. To a solution of 4-chlorophenylsulfanylacetic acid 4-Cl-C6H4SCH2COOH (20.25 g, 0.1 mol) in MeOH (100 ml), was added dropwise a methanol (50 ml) solution of tris-(2-hydroxyethyl)amine (14.92 g, 0.1 mol). The mixture was stirred at 25°C for 30 min. The solvent was distilled in vacuum. The solid residue was repeatedly washed with ether and dried in vacuum to afford colorless powder (34.64 g, 98.5% yield), m.p. 90–92°C. For analytical characterization - see .
Compound ( 2 ): To the solution of 7.03 g (0.02 mol) of 1 (m.p. 91°С) in 20 ml of МеOН the solution of 1.63 g (0.01 mol) ZnCl2 · 1.5Н2O in 5 ml of МеOН was added dropwise. The reaction mixture was stirred at 25°С for 12 h, the solvent was removed in a vacuum. The solid residue was thoroughly washed with ether and dried over Р2O5 in a vacuum. 2 (3.71 g, 43%) of colorless powder was obtained, m.p. 152°С, readily soluble in alcohols and moderately in H2O. IR: 1439 νs(COO), 1553 νas(COO), 3305 (ОН). 1Н NMR (100 MHz, d 4 -methanol): 7.30 -7.23 (4H, m, С6Н4), 3.84 (6H, t, OСН2), 3.63 (2H br s, SСН2), 3.28 (6H, t, NСН2). 13С NMR (400 MHz, d 4 -methanol): 174.82 (С = O), 135.84-128.2 (С6Н4), 55.52 (OСН2), 55.20 (NСН2), 37.37 (SСН2). Anal. Calc. for С28Н44O10S2N2Cl4Zn: С 40.00; Н 5.24; Cl 16.90; S 7.62; Zn. 7.78. Found: С 39.67; Н 5.78; Сl 16.97; S 8.26; Zn 7.82.
Compound (3): To the solution of 1 (0.703 g, 0.002 mol) in methanol (10 ml) was added dropwise a methanol solution (10 ml) of NiCl2 · 6H2O (0.237 g, 0.001 mol). The reaction mixture was stirred at 25°С for 15 h. The solvent was distilled in vacuum to give light-green powder 3, m.p. 170°С. Yield 0.55 g (59%). Well soluble in Н2О, less soluble in alcohols. IR: 1401 νs(COO), 1583 νas(COO), 3312 (ОН). 1Н NMR (100 MHz, d 4 -methanol): 7.33-7.01 (4Н, m, С6Н4S), 3.91 (6Н, t, ОСН2), 3.65 (2Н, c, SСН2), 3.44 (6Н, t, NСН2). 13С NMR (400 MHz, d 4 -methanol): 177.09 (С = О), 131.76 –128.25 (С6Н4S), 55.33 (ОСН2), 54.98 (NСН2), 37.69 (SСН2). Anal. Calc. for С28Н44Cl4N2О10S2Ni: C 40.30; H 5.27; Cl 17.01; Ni 7.04. Found: C 41.13; H 4.99; Cl 17.29; Ni 6.88.
Zinc di-(4-chlorphenylsulfanyl)acetate dihydrate (4): 0.5 g of 2 was dissolved in 10 ml of aqueous alcohol upon stirring (75°C), the solution was kept for one month at room temperature and filtered. The solid residue was washed with ether and dried over Р2O5 to obtain colorless plate crystals 4 with m.p. 202°С. IR: 1416 νs(COO), 1540 νas(COO), 3240 (ОН). 1Н NMR (100 MHz, d 4 -methanol): 7.31-7.21 (4H, m, С6Н4), 3.63 (2H, br.s, SСН2). 13С NMR (400 MHz, d 4 -methanol): 175.02 (С = O), 131.80-128.65 (С6Н4), 37.37 (SСН2). Anal. Calc. for С16Н16O6S2Cl2Zn: С 38.01; Н 3.17; Zn 12.95. Found: С 38.17; Н 3.18; Zn 12.82.
Bis-[(tris-2-hydroxyethyl)ammonium]nickel(II) di-(4-chlorphenylsulfanyl)acetate (5): From a solution 3 (aqueous alcohol, 75°C), the blue crystals 5 were obtained (20°C, for one month), m.p. 176о С. 1Н NMR (100 MHz, d 4 -methanol): 7.13-6.79 (4Н, m, С6Н4S), 3.49 (6Н, t, ОСН2), 3.29 (2Н, c, SСН2), 2.67 (6Н, t, NСН2). 13С NMR (400 MHz, d 4 -methanol): 178.90 (С = О), 136.16 -128.40 (С6Н4S), 56.50 (ОСН2), 54.43 (NСН2), 37.62 (SСН2). Anal. Calc. for C28H42Cl2N2O10S2Ni: C 44.18; H 5.79; Cl 9.33; Ni 7.72. Found: С 43.88; Н 5.63; Cl 9.54; Ni, 8.01.
Crystal data of 5
C 28 H 42 Cl 2 N 2 NiO 10 S 2 , M = 760.37, triclinic, a = 8.0020(8), b = 9.4980(10), c = 11.6401(12) Å, V = 823.29(15) Å 3 , T = 210(2) K, space group P - 1 (no.2), Z = 1, μ(MoKα) = 0.936 mm -1 ; 5252 reflections measured, 2714 unique (R int = 0.031) which were used in all calculations. Final R values: wR 2 (F 2 ) = 0.0603, R 1 = 0.0445 (all data); wR 2 (F 2 ) = 0.0575, R 1 = 0.0300 [I > 2σ)].
The reaction of pharmacological active ionic liquid H+N(CH2CH2OH)3 ∙ (-OOCCH2SC6H4Cl-4) (1) with zinc or nickel chloride affords stable at room temperature powder-like adducts [H+N(CH2CH2OH)3]2 ∙ [M(OOCCH2SC6H4Cl-4)2Cl2]2-, M = Zn (2), Ni (3). By recrystallization compound 2 unexpectedly gives Zn(OOCCH2SC6H4Cl-4)2 ∙ 2H2O (4). Unlike 2, compound 3 gives crystals [N(CH2CH2OH)3]2Ni2+ · [-OOCCH2SC6H4Cl-4]2(5), which have a structure of metallated ionic liquid. It is the first example of the conversion of a protic ionic liquid into metallated ionic liquid (compound 1 → 3 → 5). The structure of 5 has been proved by X-ray diffraction analysis. The investigation of physiological activity of metallated ionic liquids will be conducted in a new future.
- Wasserscheid P, Welton T: Ionic liquids in synthesis wiley-VCH GmbH & KGaA. 2008, Germany: WeinheimGoogle Scholar
- Hallett JP, Welton T: Room-temperature ionic liquids: solvents for synthesis and catalysis. 2. Chem Rev. 2011, 111: 3508-3576. 10.1021/cr1003248.View ArticleGoogle Scholar
- Bica K, Rijksen C, Nieuwenhuyzen M, Rogers RD: In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid. Phys Chem Chem Phys. 2010, 12: 2011-2017. 10.1039/b923855g.View ArticleGoogle Scholar
- Gabriel S: Ueber vinylamin und bromäthylamin. 2. Chemische Berichte. 1888, 21 (2): 2664-2669.Google Scholar
- Bicak N: A new ionic liquid: 2-hydroxy ethylammonium formate. J Mol Liquids. 2005, 116: 15-18. 10.1016/j.molliq.2004.03.006.View ArticleGoogle Scholar
- Alizadeh A, Khodaei MM, Eshghi A: Ambiphilic dual activation role of a task-specific ionic liquid: 2-hydroxyethylammonium formate as a recyclable promoter and medium for the green synthesis of β-nitrostyrenes. J Org Chem. 2010, 75: 8295-8298. 10.1021/jo101696z.View ArticleGoogle Scholar
- Zhang Q, Zhang S, Deng Y: Recent advances in ionic liquid catalysis. Green Chem. 2011, 13: 2619-2637. 10.1039/c1gc15334j.View ArticleGoogle Scholar
- Pinkert A, Marsh KN, Pang S: Alkanolamine ionic liquids and their inability to dissolve crystalline cellulose. Ind Eng Chem Res. 2010, 49: 11809-11813. 10.1021/ie101250v.View ArticleGoogle Scholar
- Mann JP, McCluskey A, Atkin R: Activity and thermal stability of lysozyme in alkylammonium formate ionic liquids - influence of cation modification. Green Chem. 2009, 11: 785-792. 10.1039/b900021f.View ArticleGoogle Scholar
- Hekmat D, Hebel D, Joswig S, Schmidt M, Weuster-Botz D: Advanced protein crystallization using water-soluble ionic liquids as crystallization additives. Biotechnol Lett. 2007, 29: 1703-1711. 10.1007/s10529-007-9456-9.View ArticleGoogle Scholar
- Greaves TL, Kennedy DF, Mudie ST, Drummond SJ: Diversity observed in the nanostructure of protic ionic liquids. J Phys Chem B. 2010, 114: 10022-10031. 10.1021/jp103863z.View ArticleGoogle Scholar
- Pavlovica S, Zicmanis A, Gzibovska E, Klavins M, Peteris M: (2-Hydroxyethyl)ammonium lactates - highly biodegradable and essentially Non-toxic ionic liquids. Green Sustain Chem. 2011, 1: 103-110. 10.4236/gsc.2011.13017.View ArticleGoogle Scholar
- Wood N, Ferguson JL, Nimal Gunaratne HQ, Seddon KR, Goodacre R, Stephens RG: Screening ionic liquids for use in biotransformations with whole microbial cells. Green Chem. 2011, 13: 1843-1851. 10.1039/c0gc00579g.View ArticleGoogle Scholar
- Kolesnikova OP, Mirskova AN, Adamovich SN, Mirskov RG, Kudaeva OT, Voronkov MG: Alkanolammonium salts of o-cresoxy- and p-chlorocresoxyacetic acids as immunopoiesis modulators and cytostatics. Dokl Biol Sci. 2009, 425: 107-111. 10.1134/S0012496609020070.View ArticleGoogle Scholar
- Voronkov MG, Sofronov GA, Starchenko DA, Adamovich SN, Mirskova AN: Protective properties of chlorocresacine against adverse impact of electromagnetic radiation. Dokl Biol Sci. 2009, 428: 398-402. 10.1134/S0012496609050020.View ArticleGoogle Scholar
- Mirskova AN, Adamovich SN, Mirskov RG, Voronkov MG: Tris-(2-hydroxyethyl)ammonium 2-methyl- and 2-methyl-4-chlorophenoxyacetate serve as effective inhibitors of thrombocyte aggregation and antioxidants. Dokl Biol Sci. 2010, 433: 244-246. 10.1134/S0012496610040022.View ArticleGoogle Scholar
- Mirskova AN, Mirskov RG, Adamovich SN, Voronkov MG: Indole-3-ylsulfonyl acetate tris-(2-hydroxy-ethyl)ammonium is an effective antioxidant and cell membranes stabilizer. Dokl Biol Sci. 2010, 435: 390-392. 10.1134/S0012496610060050.View ArticleGoogle Scholar
- Mirskova AN, Levkovskaya GG, Kolesnikova OP, Perminova OM, Rudyakova EV, Adamovich SN: Directed synthesis and immunoactive properties of (2-hydroxyethyl)ammonium salts of 1-R-indol-3-ylsulfanyl-(sulfonyl)alkanecarboxylic acids. Russ Chem Bull (Engl Transl). 2010, 59: 2236-2246. 10.1007/s11172-010-0384-9.View ArticleGoogle Scholar
- Mirskova AN, Mirskov RG, Adamovich SN, Voronkov MG: 2-Hydroxyethylammonium salts organylsulfanyl(sulfonyl)acetic acids - new pharmacolocical compounds. Russ J Chem Sustainable Develop (Engl Transl). 2011, 19: 467-478.Google Scholar
- Gupta MN, Raghava S: Relevance of chemistry to white biotechnology. Chem Central J. 2007, 1: 17-10.1186/1752-153X-1-17.View ArticleGoogle Scholar
- Mirskova AN, Levkovskaya GG, Mirskov RG, Voronkov MG: Hydroxyalkylammonium salts of organylsulfanyl(sulfonyl)acetic acids - New stimulators of biological processes. Russ J Org Chem. 2008, 44: 1478-1485. 10.1134/S1070428008100126.View ArticleGoogle Scholar
- Rasulov MM, Voronkov MG, Nurbekov MK, Zvereva MV, Mirskova AN, Adamovich SN, Mirskov RG: Complex bis-(2-methylphenoxyacetate)zinc with tris-2(hydroxyethyl)amine - as a activator of synthesis of total triptophanyl - tRNA-synthetase. Dokl Biol Sci. 2012, 444: 219-222.Google Scholar
- Gielen M, Tiekink ERT: Metallotherapeutic drugs and metal-based diagnostic agent. The use of metals in medicine. 2005, Chichester, UK: Wiley & Sons Ltd,View ArticleGoogle Scholar
- Oberleas D, Harland BF, Skalny AV: The biological role of macro and trace elements in humansand animals. 2008, St. Petersburg: Nauka,Google Scholar
- Guo H-X, Du ZX, Li XZ: Bis(triethanolamine)nickel(II) sulfate. Acta Crystallogr Sect E Struct Rep. 2009, 65: m810-m811. 10.1107/S1600536809023046. Online available. http://journals.iucr.org/e/issues/2009/07/00/pk2167/pk2167.pdf,View ArticleGoogle Scholar
- Haukka M, Kirillov AM, Kopylovich MN, Pombeiro AJL: Bis(triethanolamine-κ3N,O,O’)nickel(II) benzene-1,4-dicarboxylate. Acta Crystallogr Sect E Struct Rep. 2005, 61: m2746-m2748. 10.1107/S1600536805039127. Online available. http://journals.iucr.org/e/issues/2005/12/00/rn6069/index.html,View ArticleGoogle Scholar
- Sheldrick GM: SHELXS-97: Program for the solution of crystal structures. 1997, Germany: University of GöttingenGoogle Scholar
- Sheldrick GM: SHELXL-97, Program for the refinement of crystal structures. 1997, Germany: University of GöttingenGoogle Scholar
- Brandenburg K: Diamond. 2005, Bonn: Crystal Impact, Version 31Google Scholar
- Levkovskaya GG, Guseva SA, Kazimirovskaya VB, Kholdeeva LN, Voronkov MG, Мirskova AN: 2-Hydroxyalkylammonium salts aryltioacetic asides and there influense on functional activity of trombosides. II. Russ Chem Pharm J. 1986, 22: 295-300.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.